Skip to main
TSBX
TSBX logo

TSBX P/E Ratio

P/E Ratio as of Jun 13, 2025: -0.12

Average-0.1252
Median-0.1300
Minimum-0.1300
Maximum-0.1100
-0.12
Past Month+0.01 (7.69%)
The P/E ratio for TSBX is -0.12 as of Jun 13, 2025. This represents a decrease of -52.00% compared to its 12-month average P/E ratio of -0.25. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Turnstone Biologics Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Turnstone Biologics Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Turnstone Biologics Corp to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

TSBX P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$0.3127-0.11
May 1, 2025$0.3475-0.11
Apr 1, 2025$0.376-0.12
Mar 3, 2025$0.355-0.11
Feb 3, 2025$0.4086-0.13
Jan 2, 2025$0.5375-0.17

TSBX End of Year P/E Ratio

DateP/E ratioChange
2025-0.12-20.00%
2024-0.15

FAQs About Turnstone Biologics Corp (TSBX) P/E ratio

The latest P/E ratio of TSBX is -0.12, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Turnstone Biologics Corp’s last 12-month average P/E ratio is -0.25, compared to its current P/E ratio of -0.12. This reflects a decrease of -52.00%.

Turnstone Biologics Corp’s current P/E ratio of -0.12 is lower than its last 12-month average P/E of -0.25. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Turnstone Biologics Corp’s average P/E ratio over the last 3 years is -0.27. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Turnstone Biologics Corp’s average P/E ratio over the last 5 years is -0.16. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Turnstone Biologics Corp (TSBX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.